Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.2K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Standard Precaution01:26

Standard Precaution

2.3K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.3K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

4.2K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.6K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Cleaning, Sterilization, and Disinfection01:30

Cleaning, Sterilization, and Disinfection

7.9K
Cleaning, disinfection, and sterilization are the methods that help to break the infection chain and prevent disease.
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
7.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

497
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
497

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Prokinetic Agents in Adult ICU Patients: An International Inception Cohort Study (PATIENCE).

Acta anaesthesiologica Scandinavica·2026
Same author

Developing a Core Outcome Measurement Set for Adult ICU Patients, the CoreMS-ICU-A Protocol.

Acta anaesthesiologica Scandinavica·2026
Same author

Preferences for Blood Glucose Management in Adult Intensive Care Unit Patients-An International Survey.

Acta anaesthesiologica Scandinavica·2026
Same author

ICU Clinicians' View on Platelet Transfusion Thresholds for a Future Trial-Protocol for an International Survey.

Acta anaesthesiologica Scandinavica·2026
Same author

Cognitive Rehabilitation Interventions in the Intensive Care Unit: A Systematic Integrative Review.

Acta anaesthesiologica Scandinavica·2026
Same author

Restrictive versus standard intravenous fluid therapy and NTproBNP in ICU patients with septic shock - a sub-study of the randomised CLASSIC trial.

BMC anesthesiology·2026
Same journal

Cefiderocol heteroresistance in NDM Enterobacterales.

The Lancet. Infectious diseases·2026
Same journal

Correction to Lancet Infect Dis 2020; 20: 37-59.

The Lancet. Infectious diseases·2026
Same journal

Correction to Lancet Infect Dis 2020; 20: 60-79.

The Lancet. Infectious diseases·2026
Same journal

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026
Same journal

The Bundibugyo virus disease outbreak: a warning signal for risks to health workers.

The Lancet. Infectious diseases·2026
Same journal

Trials of medical countermeasures to begin in DR Congo.

The Lancet. Infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Oct 13, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K

Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.

Prashant Nasa1, Elie Azoulay2, Arunaloke Chakrabarti3

  • 1NMC Speciality Hospital, Dubai, United Arab Emirates.

The Lancet. Infectious Diseases
|November 14, 2021
PubMed
Summary
This summary is machine-generated.

International experts developed 25 consensus statements for infection control in intensive care units (ICUs) during the COVID-19 pandemic. These guidelines address SARS-CoV-2 transmission risks for healthcare workers and patients.

More Related Videos

Determining Viral Disinfection Efficacy of Hot Water Laundering
06:57

Determining Viral Disinfection Efficacy of Hot Water Laundering

Published on: June 21, 2022

2.7K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.1K

Related Experiment Videos

Last Updated: Oct 13, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K
Determining Viral Disinfection Efficacy of Hot Water Laundering
06:57

Determining Viral Disinfection Efficacy of Hot Water Laundering

Published on: June 21, 2022

2.7K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.1K

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Public Health

Background:

  • Healthcare workers and patients in intensive care units (ICUs) face SARS-CoV-2 infection risks.
  • Variable infection control practices in ICUs due to limited evidence on SARS-CoV-2 transmission.
  • Urgent need for standardized infection control guidelines in critical care settings.

Purpose of the Study:

  • To establish consensus-based clinical practice statements for SARS-CoV-2 infection control in ICUs.
  • To provide evidence-informed guidance for healthcare professionals managing COVID-19 patients in critical care.
  • To address uncertainties and improve patient and healthcare worker safety in ICUs.

Main Methods:

  • A Delphi process involving international experts in intensive care, infectious diseases, and infection control.
  • Development and voting on 33 statements related to SARS-CoV-2 infection control in ICUs.
  • Consensus building to achieve agreement on clinical practice recommendations.

Main Results:

  • Consensus reached on 31 out of 33 statements (94% agreement).
  • 25 clinical practice statements were issued, covering ICU design, healthcare worker safety, PPE, patient management, and disinfection.
  • Disagreement persisted on return-to-work criteria for infected healthcare workers and disinfection of heat-sensitive instruments.

Conclusions:

  • Consensus statements provide crucial guidance for SARS-CoV-2 infection control in ICUs.
  • Further research is needed to address areas of non-consensus and evaluate the impact of implemented practices.
  • Standardized infection control measures are vital to mitigate transmission risks in critical care environments.